Pages that link to "Q45972929"

The following pages link to Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. (Q45972929):

Displaying 39 items.

• New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy (Q26765468) (← links)
• Vascular Endothelial Growth Factor and Diabetic Retinal Disease (Q35950867) (← links)
• Automated Quantification of Capillary Nonperfusion Using Optical Coherence Tomography Angiography in Diabetic Retinopathy (Q37161300) (← links)
• Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections (Q37608621) (← links)
• Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States (Q38650949) (← links)
• Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus. (Q38955628) (← links)
• Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy. (Q39593443) (← links)
• Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy (Q39941359) (← links)
• Advanced image processing for optical coherence tomographic angiography of macular diseases. (Q40162708) (← links)
• Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy (Q41498626) (← links)
• Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia (Q47139871) (← links)
• Recent advances in the management and understanding of diabetic retinopathy (Q47168388) (← links)
• VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema. (Q47243737) (← links)
• 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy. (Q48349526) (← links)
• Management of diabetic macular edema in Japan: a review and expert opinion (Q48579709) (← links)
• Fundus fluorescence Angiography in diagnosing diabetic retinopathy. (Q50325304) (← links)
• Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop. (Q55312812) (← links)
• Ranibizumab: A Review of Its Use in the Treatment of Diabetic Retinopathy in Patients With Diabetic Macular Edema. (Q55316713) (← links)
• Automated segmentation of retinal layer boundaries and capillary plexuses in wide-field optical coherence tomographic angiography (Q58704425) (← links)
• The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy (Q58762667) (← links)
• Investigating the Fractal Dimension of the Foveal Microvasculature in Relation to the Morphology of the Foveal Avascular Zone and to the Macular Circulation in Patients With Type 2 Diabetes Mellitus (Q58762930) (← links)
• Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis (Q58762933) (← links)
• Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy (Q60918636) (← links)
• Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study (Q61798227) (← links)
• ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION (Q64253957) (← links)
• Time to Call into Question the Fundus-based Evaluation of Diabetic Retinopathy after Intravitreal Injections (Q89868232) (← links)
• Emerging Insights and Interventions for Diabetic Retinopathy (Q90046873) (← links)
• Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema (Q90215399) (← links)
• Parafoveal Nonperfusion Analysis in Diabetic Retinopathy Using Optical Coherence Tomography Angiography (Q90223553) (← links)
• The Evolving Treatment of Diabetic Retinopathy (Q90409273) (← links)
• Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy (Q90479204) (← links)
• How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodology (Q92100799) (← links)
• Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Q92406505) (← links)
• Management of diabetes complications in youth (Q92435007) (← links)
• Females with Type 2 Diabetes Mellitus Are Prone to Diabetic Retinopathy: A Twelve-Province Cross-Sectional Study in China (Q94596430) (← links)
• Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema (Q95641816) (← links)
• Restoration of Foveal Bulge after Resolution of Diabetic Macular Edema with Coexisting Serous Retinal Detachment (Q97075348) (← links)
• Clinical effect of conbercept on improving diabetic macular ischemia by OCT angiography (Q99726333) (← links)
• Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes (Q101237412) (← links)